{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:18:44Z","timestamp":1791177524801,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ejca.2013.02.020","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T02:20:35Z","timestamp":1363141235000},"page":"2253-2263","source":"Crossref","is-referenced-by-count":15,"title":["A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis"],"prefix":"10.1016","volume":"49","author":[{"given":"Steven","family":"Georges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Chesneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soizic","family":"Hervouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Taurelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Redini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Padrines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Fortun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Verrecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.02.020_b0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ejca.2013.02.020_b0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.biocel.2008.01.025","article-title":"Cellular roles of ADAM12 in health and disease","volume":"40","author":"Kveiborg","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejca.2013.02.020_b0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1559-0275-8-9","article-title":"The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?","volume":"8","author":"Duffy","year":"2011","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.ejca.2013.02.020_b0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1349-7006.2007.00434.x","article-title":"ADAMs in cancer cell proliferation and progression","volume":"98","author":"Mochizuki","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejca.2013.02.020_b0025","doi-asserted-by":"crossref","first-page":"51323","DOI":"10.1074\/jbc.M409565200","article-title":"ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage","volume":"279","author":"Roy","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.02.020_b0030","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-05-0262","article-title":"A role for ADAM12 in breast tumor progression and stromal cell apoptosis","volume":"65","author":"Kveiborg","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.02.020_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.acthis.2011.03.009","article-title":"Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics","volume":"114","author":"Narita","year":"2012","journal-title":"Acta Histochem"},{"key":"10.1016\/j.ejca.2013.02.020_b0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/sj.bjc.6602990","article-title":"Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC)","volume":"94","author":"Rocks","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2013.02.020_b0045","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1158\/1078-0432.CCR-06-1066","article-title":"Molecular profiling of ADAM12 in human bladder cancer","volume":"12","author":"Fr\u00f6hlich","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2013.02.020_b0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jso.21313","article-title":"A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma","volume":"100","author":"Mino","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.02.020_b0055","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)63429-3","article-title":"ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor","volume":"165","author":"Kodama","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2013.02.020_b0060","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1158\/1055-9965.EPI-07-0365","article-title":"Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment","volume":"17","author":"Pories","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2013.02.020_b0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.sempedsurg.2005.11.005","article-title":"Management of osteosarcoma pulmonary metastases","volume":"15","author":"Harting","year":"2006","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.ejca.2013.02.020_b0070","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/annonc\/mdg286","article-title":"Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide","volume":"14","author":"Bacci","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2013.02.020_b0075","first-page":"693","article-title":"Osteosarcoma: current status of immunotherapy and future trends (Review)","volume":"15","author":"Mori","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejca.2013.02.020_b0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/14656566.2011.543129","article-title":"Mifamurtide for the treatment of nonmetastatic osteosarcoma","volume":"12","author":"Ando","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejca.2013.02.020_b0085","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1517\/13543784.2011.577064","article-title":"Targeted therapies in bone sarcomas: current approach and future directions","volume":"20","author":"Yarber","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ejca.2013.02.020_b0090","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2174\/138161210793563554","article-title":"Therapeutic approach of primary bone tumours by bisphosphonates","volume":"16","author":"Moriceau","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejca.2013.02.020_b0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3835(02)00433-0","article-title":"Inhibition of lung metastasis of osteosarcoma cell line POS-1 transplanted into mice by thigh ligation","volume":"188","author":"Kamijo","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2013.02.020_b0100","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.4049\/jimmunol.177.9.6129","article-title":"Complex interplay of activating and inhibitory signals received by V\u03b39V\u03b42 T cells revealed by target cell \u03b22-microglobulin knockdown","volume":"177","author":"Trichet","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2013.02.020_b0105","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/0008-5472.CAN-04-2128","article-title":"Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma","volume":"65","author":"Cao","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.02.020_b0110","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/jbmr.455","article-title":"Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models","volume":"26","author":"Rousseau","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ejca.2013.02.020_b0115","first-page":"223","article-title":"Establishment and characterization of a new osteogenic cell line (MOS-J) from a spontaneous C57BL\/6J mouse osteosarcoma","volume":"16","author":"Joliat","year":"2002","journal-title":"In Vivo"},{"key":"10.1016\/j.ejca.2013.02.020_b0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm0102-35","article-title":"Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy","volume":"8","author":"Asakura","year":"2002","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ejca.2013.02.020_b0125","first-page":"0010","article-title":"A comprehensive pathway map of epidermal growth factor receptor signaling","volume":"2005","author":"Oda","year":"2005","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.ejca.2013.02.020_b0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jcp.1041390309","article-title":"Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels","volume":"139","author":"Mioh","year":"1989","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2013.02.020_b0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.yexcr.2004.04.005","article-title":"Interaction of the disintegrin and cysteine-rich domains of ADAM12 with integrin alpha7beta1","volume":"298","author":"Zhao","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ejca.2013.02.020_b0140","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1083\/jcb.149.5.1143","article-title":"The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading","volume":"149","author":"Iba","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ejca.2013.02.020_b0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor\u2013bone interactions in osteolytic metastases","volume":"10","author":"Chirgwin","year":"2000","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.ejca.2013.02.020_b0150","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2013.02.020_b0155","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1006\/bbrc.2000.2569","article-title":"Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts","volume":"270","author":"Grano","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.02.020_b0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1210\/endo-107-1-270","article-title":"Direct stimulation of bone resorption by epidermal growth factor","volume":"107","author":"Raisz","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejca.2013.02.020_b0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00223001128","article-title":"Down-regulation of osteoblastic cell differentiation by epidermal growth factor receptor","volume":"67","author":"Chien","year":"2000","journal-title":"Calcif Tissue Int"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T22:56:28Z","timestamp":1562799388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804913001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0959804913001500"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.02.020","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}